Fatty acid synthase (FAS) is a recently discovered molecule involved in the energy supply to normal cells. FAS is overexpressed in neoplastic tissues because of their increased energy needs. We explored the immunohistochemical expression of FAS, Ki-67 and p53 in squamous cell carcinomas (SCC) of the larynx and their association with clinicopathological features and outcome. Specimens from 43 patients with SCC were evaluated. Statistical analysis revealed an association between poorly differentiated laryngeal carcinomas and FAS expression (p<0.005) and between FAS and Ki-67 overexpression (p<0.001). Finally, FAS expression was associated with overall survival (p<0.001). We suggest that FAS is a powerful prognostic indicator whose strength can be enhanced when it is evaluated together with clinicopathological data and Ki-67 expression.
World Health Organization.Bulletin of the World Health Organization.Geneva: World Health Organization, 2005.
4.
KuhajdaF.P.. Fatty acid synthase in human cancer: new perspectives on its role in tumor biology.Nutrition2000; 16: 202–8.
5.
BaronA., MigitaT., TangD., LodaM.. Fatty acid synthase: a metabolic oncogene in prostate cancer?J Cell Biochem2004; 91: 47–53.
6.
WeissL., HoffmannG.E., SchreiberR.. Fatty acid biosynthesis in man, a pathway of minor importance. Purification, optimal assay conditions, and organ distribution of fatty acid synthase.Biol Chem Hoppe Seyler1986; 367: 905–12.
7.
KuhajdaF.P., JennerK., WoodF.W.. Fatty acid synthesis: a potential selective target for anti-neoplastic therapy.Proc Natl Acad Sci USA1994; 91: 6379–83.
8.
PizerE.S., WoodF.D., HeineH.S., RomantsevF.E., PasternackG.R., KuhajdaF.P.. Inhibition of fatty acid synthesis delays disease progression in a xenograft model of ovarian cancer.Cancer Res1996; 56: 1189–93.
9.
KrontirasH., RoyeG.D., BeenkenS.E.. Fatty acid synthase expression is increased in neoplastic lesions of the oral tongue.Head Neck1999; 21: 325–9.
10.
OskouianB.. Overexpression of fatty acid synthase in SKBR3 breast cancer cell line is mediated via a transcriptional mechanism.Cancer Lett2000; 149: 43–51.
11.
PiyathilakeC.J., FrostA.R., ManneU.. The expression of fatty acid synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lung.Hum Pathol2000; 31: 1068–73.
12.
DhanasekaranS.M., BarretteT.R., GhoshD.. Delineation of prognostic biomarkers in prostate cancer.Nature2001; 412: 822–6.
13.
ShurbajiM.S., KalbfleishJ.H., ThurmondT.S.. Immunohistochemical detection of a fatty acid synthase (AO-519) as a predictor of progression of prostate cancer.Hum Pathol1996; 27: 917–21.
14.
KusakabeT., NashimotoA., HonmaK., SuzukiT.. Fatty acid synthase is highly expressed in carcinoma, adenoma and in regenerative epithelium and intestinal metaplasia of the stomach.Histophatology2002; 40: 71–9.
15.
SwinnenJ.V., RoskamsT., JoniauS.. Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer.Int J Cancer2002; 98: 19–22.
RossiS., GranerE., FebboP.. Fatty acid synthase expression defines distinct molecular signatures in prostate cancer.Mol Cancer Res2003; 1: 707–15.
18.
ViscaP., SebastianiV., PizerE.S.. Immunohistochemical expression and prognostic significance of FAS and GLUT1 in bladder carcinoma.Anticancer Res2003; 23: 335–9.
19.
TakahiroT., ShinichiK., ToshimitsuS.. Expression of fatty acid synthase as a prognostic indicator in soft tissue sarcomas.Clin Cancer Res2003; 9: 2204–12.
20.
AlòP.L., ViscaP., MarciA., MangoniA., BottiC., Di TondoU.. Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients.Cancer1996; 77: 474–82.
21.
AlòP.L., ViscaP., FramarinoM.L.. Immunohistochemical study of fatty acid synthase in ovarian neoplasm.Oncol Rep2000; 7: 1383–8.
22.
FuruyaY., AkimotoS., YasudaK., ItoH.. Apoptosis in androgen-in-dependent prostate cell line induced by inhibition of fatty acid synthesis.Anticancer Res1997; 17: 4589–93.
23.
PizerE.S., ChrestF.J., Di GiuseppeJ.A., HanW.F.. Pharmacological inhibitors of mammalian fatty acid synthase suppress DNA replication and induce apoptosis in tumor cell lines.Cancer Res1998; 58: 4611–5.
24.
LiJ.N., GorospeM., ChrestF.J.. Pharmacological inhibition of fatty acid synthase activity produces both cytostatic and cytotoxic effects modulated by p53.Cancer Res2001; 61: 1493–9.
25.
BaronA., MigitaT., TangD., LodaM.. Fatty acid synthase: a metabolic oncogene in prostate cancer?J Cell Biochem2004; 91: 47–53.
26.
MenendezJ.A., DeckerJ.P., LupuR.. In support of fatty acid synthase (FAS) as a metabolic oncogene: extracellular acidosis acts in an epigenetic fashion activating FAS gene expression in cancer cells.J Cell Biochem2005; 94: 1–4.
27.
LuS., ArcherM.C.. Fatty acid synthase is a potential molecular target for the chemoprevention of breast cancer.Carcinogenesis2005; 26: 153–7.
28.
GabrielsonE.W., PinnM.L., TestaJ.R., KuhajdaF.P.. Increased fatty acid synthase is a therapeutic target in mesothelioma.Clin Cancer Res2001; 7: 153–7.
29.
SilvaS.D., AgostiniM., NishimotoI.N.. Expression of fatty acid synthase, ErbB2 and Ki-67 in head and neck squamous cell carcinoma. A clinicopathological study.Oral Oncol2004; 40: 688–96.
30.
AgostiniM., SilvaS.D., ZecchinK.G.. Fatty acid synthase is required for the proliferation of human oral squamous carcinoma cells.Oral Oncol2004; 40: 728–35.
31.
KusakabeT., MaedaM., HoshiN.. Fatty acid synthase is expressed mainly in adult hormone-sensitive cells or cells with high lipid metabolism and in proliferating fetal cells.J Histochem Cytochem2000; 48: 613–22.
